Kazuki Terashima

2.0k total citations
72 papers, 1.4k citations indexed

About

Kazuki Terashima is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Hepatology. According to data from OpenAlex, Kazuki Terashima has authored 72 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 23 papers in Surgery and 18 papers in Hepatology. Recurrent topics in Kazuki Terashima's work include Radiation Therapy and Dosimetry (21 papers), Hepatocellular Carcinoma Treatment and Prognosis (18 papers) and Pancreatic and Hepatic Oncology Research (9 papers). Kazuki Terashima is often cited by papers focused on Radiation Therapy and Dosimetry (21 papers), Hepatocellular Carcinoma Treatment and Prognosis (18 papers) and Pancreatic and Hepatic Oncology Research (9 papers). Kazuki Terashima collaborates with scholars based in Japan, United States and Russia. Kazuki Terashima's co-authors include Yusuke Demizu, Masao Murakami, Ryohei Sasaki, Y. Niwa, Yoshio Hishikawa, M. Mima, Nobukazu Fuwa, Osamu Fujii, Takashi Akagi and Daisuke Miyawaki and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Kazuki Terashima

66 papers receiving 1.3k citations

Peers

Kazuki Terashima
Kazuki Terashima
Citations per year, relative to Kazuki Terashima Kazuki Terashima (= 1×) peers Osamu Fujii

Countries citing papers authored by Kazuki Terashima

Since Specialization
Citations

This map shows the geographic impact of Kazuki Terashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuki Terashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuki Terashima more than expected).

Fields of papers citing papers by Kazuki Terashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuki Terashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuki Terashima. The network helps show where Kazuki Terashima may publish in the future.

Co-authorship network of co-authors of Kazuki Terashima

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuki Terashima. A scholar is included among the top collaborators of Kazuki Terashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuki Terashima. Kazuki Terashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Komatsu, Shohei, Kazuki Terashima, Jun Ishida, et al.. (2025). The potential efficacy of atezolizumab plus bevacizumab treatment for hepatocellular carcinoma patients with macroscopic portal vein tumor thrombus. Surgery Today. 55(7). 900–908.
2.
Terashima, Kazuki, Masayuki Nagahashi, Koji Morimoto, et al.. (2024). Highly efficient and selective anticancer approach through acrolein-triggered cycloaddition chemistry in patient-derived xenografts: Mechanistic and preclinical investigation. SHILAP Revista de lepidopterología. 12. 100094–100094. 3 indexed citations
3.
Kubota, Hikaru, Yusuke Demizu, Nobuyoshi Fukumitsu, et al.. (2024). Definitive particle therapy using protons or carbon ions for dedifferentiated liposarcoma. Clinical and Translational Radiation Oncology. 49. 100864–100864. 1 indexed citations
4.
Terashima, Kazuki, Jun Ishida, Yoshihide Nanno, et al.. (2023). Proton radiotherapy as a treatment strategy to increase survival in locally advanced pancreatic cancer in the body and tail: a retrospective study. Radiation Oncology. 18(1). 131–131. 1 indexed citations
5.
Shiba, Shintaro, Masaru Wakatsuki, Shingo Toyama, et al.. (2023). Carbon‐ion radiotherapy for oligometastatic liver disease: A national multicentric study by the Japan Carbon‐Ion Radiation Oncology Study Group (J‐CROS). Cancer Science. 114(9). 3679–3686. 4 indexed citations
6.
Komatsu, Shohei, Kazuki Terashima, Yusuke Demizu, et al.. (2023). Clinical impact of spacer placement surgery with expanded polytetrafluoroethylene sheet for particle therapy. Radiation Oncology. 18(1). 173–173. 1 indexed citations
7.
Mizumoto, Masashi, Hiroyuki Ogino, Toshiyuki Okumura, et al.. (2023). Proton Beam Therapy for Hepatocellular Carcinoma: Multicenter Prospective Registry Study in Japan. International Journal of Radiation Oncology*Biology*Physics. 118(3). 725–733. 14 indexed citations
8.
Yamazaki, Hideya, Satoshi Teramukai, Kei Fujikawa, et al.. (2023). Particle beam therapy versus photon radiotherapy for extrahepatic biliary cancer—systemic review and meta-analysis. Journal of Radiation Research. 64(Supplement_1). i34–i40. 2 indexed citations
9.
Komatsu, Shohei, Kazuki Terashima, Daisuke Tsugawa, et al.. (2022). Space-Making Particle Therapy for Unresectable Hilar Cholangiocarcinoma. Digestive Surgery. 39(2-3). 99–108. 4 indexed citations
10.
Terashima, Kazuki, Yoshihide Nanno, Nor Shazrina Sulaiman, et al.. (2022). Factors associated with long-term survival in gemcitabine-concurrent proton radiotherapy for non-metastatic locally advanced pancreatic cancer: a single-center retrospective study. Radiation Oncology. 17(1). 32–32. 7 indexed citations
11.
Pradipta, Ambara R., et al.. (2021). Targeted 1,3-dipolar cycloaddition with acrolein for cancer prodrug activation. Chemical Science. 12(15). 5438–5449. 24 indexed citations
12.
Terashima, Kazuki, et al.. (2021). A Novel Approach to Transmission Bottleneck Management in Japan: An N-1 Intertrip Scheme. IEEE Power and Energy Magazine. 19(2). 69–78.
13.
Takagi, M., Yusuke Demizu, Osamu Fujii, et al.. (2020). Proton Therapy for Localized Prostate Cancer: Long-Term Results From a Single-Center Experience. International Journal of Radiation Oncology*Biology*Physics. 109(4). 964–974. 23 indexed citations
14.
Takagi, M., Yusuke Demizu, Kazuki Terashima, et al.. (2018). Treatment outcomes of proton or carbon ion therapy for skull base chordoma: a retrospective study. Radiation Oncology. 13(1). 232–232. 28 indexed citations
15.
Demizu, Yusuke, Dongcun Jin, Nor Shazrina Sulaiman, et al.. (2017). Particle Therapy Using Protons or Carbon Ions for Unresectable or Incompletely Resected Bone and Soft Tissue Sarcomas of the Pelvis. International Journal of Radiation Oncology*Biology*Physics. 98(2). 367–374. 41 indexed citations
16.
Morimoto, Koichi, Yusuke Demizu, Naoki Hashimoto, et al.. (2014). Particle Radiotherapy Using Protons or Carbon Ions for Unresectable Locally Advanced Head and Neck Cancers with Skull Base Invasion†. Japanese Journal of Clinical Oncology. 44(5). 428–434. 54 indexed citations
17.
Takagi, M., Yusuke Demizu, Naoki Hashimoto, et al.. (2014). Treatment outcomes of particle radiotherapy using protons or carbon ions as a single-modality therapy for adenoid cystic carcinoma of the head and neck. Radiotherapy and Oncology. 113(3). 364–370. 69 indexed citations
18.
Terashima, Kazuki, Takayuki Ose, Naoto Kitajima, et al.. (2013). Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer. Journal of Gastroenterology. 49(6). 1074–1080. 36 indexed citations
19.
Komatsu, Shohei, Takumi Fukumoto, Yusuke Demizu, et al.. (2011). Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma. Cancer. 117(21). 4890–4904. 121 indexed citations
20.
Iwata, Hiromitsu, Masao Murakami, Yusuke Demizu, et al.. (2010). High‐dose proton therapy and carbon‐ion therapy for stage I nonsmall cell lung cancer. Cancer. 116(10). 2476–2485. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026